Early Outcomes of the Evolut R Transcatheter Aortic Valve: A New Technology Between Achieved Goals and Desirable Improvements
- PMID: 28183468
- DOI: 10.1016/j.jcin.2016.12.029
Early Outcomes of the Evolut R Transcatheter Aortic Valve: A New Technology Between Achieved Goals and Desirable Improvements
Keywords: TAVR; aortic stenosis; new devices.
Comment on
-
Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study.JACC Cardiovasc Interv. 2017 Feb 13;10(3):268-275. doi: 10.1016/j.jcin.2016.08.050. JACC Cardiovasc Interv. 2017. PMID: 28183466 Clinical Trial.
-
Initial Experience of a Second-Generation Self-Expanding Transcatheter Aortic Valve: The UK & Ireland Evolut R Implanters' Registry.JACC Cardiovasc Interv. 2017 Feb 13;10(3):276-282. doi: 10.1016/j.jcin.2016.11.025. JACC Cardiovasc Interv. 2017. PMID: 28183467
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
